X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (675) 675
male (673) 673
desipramine - pharmacology (555) 555
rats (474) 474
humans (409) 409
desipramine (399) 399
pharmacology & pharmacy (311) 311
female (298) 298
neurosciences (226) 226
adult (197) 197
norepinephrine - metabolism (194) 194
dose-response relationship, drug (168) 168
psychiatry (155) 155
middle aged (149) 149
in vitro techniques (122) 122
antidepressants (119) 119
rats, sprague-dawley (119) 119
time factors (118) 118
antidepressive agents - pharmacology (117) 117
rats, inbred strains (116) 116
mice (103) 103
fluoxetine - pharmacology (101) 101
kinetics (101) 101
index medicus (100) 100
brain - metabolism (93) 93
norepinephrine (91) 91
noradrenaline (89) 89
imipramine (88) 88
desipramine - analogs & derivatives (83) 83
desipramine - therapeutic use (83) 83
serotonin - metabolism (82) 82
drug interactions (81) 81
fluoxetine (79) 79
adrenergic uptake inhibitors - pharmacology (78) 78
fluoxetine - analogs & derivatives (78) 78
biochemistry & molecular biology (75) 75
desipramine - metabolism (74) 74
serotonin (74) 74
desipramine - blood (72) 72
antidepressive agents, tricyclic - pharmacology (68) 68
depressive disorder - drug therapy (68) 68
brain (67) 67
depression (67) 67
double-blind method (67) 67
aged (65) 65
brain - drug effects (65) 65
clinical neurology (64) 64
imipramine - pharmacology (63) 63
dopamine (62) 62
imipramine - analogs & derivatives (62) 62
methoxyhydroxyphenylglycol - analogs & derivatives (61) 61
cocaine (60) 60
amitriptyline (59) 59
rats, wistar (59) 59
norepinephrine - pharmacology (57) 57
imipramine - metabolism (54) 54
dopamine - metabolism (52) 52
neurons - metabolism (52) 52
desipramine - administration & dosage (51) 51
tritium (50) 50
adolescent (49) 49
behavior, animal - drug effects (49) 49
rat (49) 49
treatment outcome (49) 49
motor activity - drug effects (48) 48
desipramine - pharmacokinetics (47) 47
cerebral cortex - metabolism (46) 46
myocardium - metabolism (46) 46
neurons - drug effects (46) 46
sertraline (46) 46
metabolism (45) 45
rat-brain (45) 45
cocaine - pharmacology (44) 44
electric stimulation (44) 44
1-naphthylamine - analogs & derivatives (42) 42
reserpine - pharmacology (42) 42
tricyclic antidepressants (42) 42
chromatography, high pressure liquid (40) 40
antidepressant (39) 39
hydroxylation (39) 39
norepinephrine plasma membrane transport proteins (39) 39
serotonin uptake inhibitors - pharmacology (39) 39
inhibition (38) 38
heart rate - drug effects (37) 37
rabbits (37) 37
cerebral cortex - drug effects (36) 36
amitriptyline - pharmacology (35) 35
norepinephrine - antagonists & inhibitors (35) 35
brain chemistry - drug effects (34) 34
imipramine - blood (34) 34
methoxyhydroxyphenylglycol - blood (34) 34
norepinephrine transporter (34) 34
pharmacokinetics (34) 34
tissue distribution (34) 34
blood pressure - drug effects (33) 33
double-blind (33) 33
sympathetic nervous system - drug effects (33) 33
analysis (32) 32
drug synergism (32) 32
drugs (32) 32
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 09/2001, Volume 45, Issue 9, pp. 2655 - 2657
Journal Article
Psychopharmacology, ISSN 0033-3158, 8/2016, Volume 233, Issue 15, pp. 2955 - 2971
Fas-associated death domain (FADD) is an adaptor of death receptors that can also induce anti-apoptotic actions through its phosphorylated form (p-FADD).... 
Neuroplasticity | Neuroprotection | Neurosciences | Biomedicine | FADD and p-FADD | Forced swim test | Anti-depressant drugs | Pharmacology/Toxicology | Psychiatry | Electroconvulsive shock | PRESYNAPTIC AUTORECEPTORS | NEUROTRANSMITTER RELEASE | PSYCHIATRY | ANTIDEPRESSANT TREATMENT | ADRENERGIC-RECEPTOR | MAJOR DEPRESSION | SUICIDE VICTIMS | NEUROSCIENCES | PREFRONTAL CORTEX | MONOAMINE-OXIDASE INHIBITORS | PHARMACOLOGY & PHARMACY | GAMMA-AMINOBUTYRIC-ACID | DEATH DOMAIN PROTEIN | Phosphoproteins - drug effects | Phenelzine - pharmacology | Autoreceptors - metabolism | Clorgyline - pharmacology | Male | Adrenergic alpha-Antagonists - pharmacology | Phosphoproteins - metabolism | Cerebral Cortex - metabolism | Idazoxan - pharmacology | Mianserin - analogs & derivatives | Mianserin - pharmacology | Desipramine - pharmacology | Fluoxetine - analogs & derivatives | Mirtazapine | Antidepressive Agents - pharmacology | Cerebral Cortex - drug effects | Phosphorylation - drug effects | RNA-Binding Proteins - antagonists & inhibitors | Fluoxetine - pharmacology | Idazoxan - analogs & derivatives | Monoamine Oxidase Inhibitors - pharmacology | Fas-Associated Death Domain Protein - drug effects | Norepinephrine Plasma Membrane Transport Proteins - antagonists & inhibitors | Fas-Associated Death Domain Protein - metabolism | Rats | Excitatory Amino Acid Antagonists - pharmacology | Blotting, Western | Brain - drug effects | Animals | CASP8 and FADD-Like Apoptosis Regulating Protein | Thiazoles - pharmacology | Ketamine - pharmacology | Electroshock | Apoptosis | Indans - pharmacology | Pharmacology, Experimental | Antidepressants | Desipramine | Fluoxetine | Psychopharmacology | Dosage and administration | Research | Proteins | Brain | Rodents
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10047, pp. 881 - 890
Summary Background Major depressive disorder is one of the most common mental disorders in children and adolescents. However, whether to use pharmacological... 
Internal Medicine | TRIALS | MEDICINE, GENERAL & INTERNAL | ACCEPTABILITY | MENTAL-HEALTH-CARE | TRENDS | GUIDELINES | Mianserin - adverse effects | Triazoles - administration & dosage | Triazoles - adverse effects | Humans | Citalopram - adverse effects | Sertraline - adverse effects | Venlafaxine Hydrochloride - adverse effects | Imipramine - administration & dosage | Paroxetine - adverse effects | Mianserin - analogs & derivatives | Paroxetine - administration & dosage | Desipramine - adverse effects | Nortriptyline - administration & dosage | Nortriptyline - adverse effects | Mianserin - administration & dosage | Child | Fluoxetine - adverse effects | Depressive Disorder, Major - drug therapy | Clomipramine - administration & dosage | Duloxetine Hydrochloride - adverse effects | Double-Blind Method | Drug Administration Schedule | Treatment Outcome | Clomipramine - adverse effects | Evidence-Based Medicine | Desipramine - administration & dosage | Randomized Controlled Trials as Topic | Venlafaxine Hydrochloride - administration & dosage | Citalopram - administration & dosage | Confounding Factors (Epidemiology) | Sertraline - administration & dosage | Adolescent | Amitriptyline - adverse effects | Bayes Theorem | Fluoxetine - administration & dosage | Duloxetine Hydrochloride - administration & dosage | Antidepressive Agents - administration & dosage | Antidepressive Agents - adverse effects | Research Design | Amitriptyline - administration & dosage | Imipramine - adverse effects | Psychological aspects | Medical colleges | Neurosciences | Drugs and youth | Rankings | Comparative analysis | Child psychopathology | Major depressive disorder | Antidepressants, Tricyclic | Pediatric pharmacology | Mental illness | Studies | Teenagers | Mental depression | Antidepressants | Meta-analysis | Children & youth
Journal Article
Journal Article
Biological Psychiatry, ISSN 0006-3223, 2011, Volume 70, Issue 10, pp. 937 - 945
Background Vagal nerve stimulation (VNS) is used for treatment-refractory depression, but there are few preclinical studies of its effects when administered... 
Psychiatry | 5,7-dihydroxytryptamine | vagal nerve stimulation | 6-hydroxydopamine | novelty suppressed feeding test | desipramine | forced swim test | sertraline | VAGUS NERVE | RAPHE NUCLEUS | TREATMENT-RESISTANT DEPRESSION | INDUCED REMISSION | NEUROSCIENCES | ANTIINFLAMMATORY CYTOKINES | MESSENGER-RNA | TRANSPORTER FUNCTION | MEDULLA-OBLONGATA | ANIMAL-MODEL | Neural Pathways - drug effects | Imipramine - analogs & derivatives | Male | Neural Pathways - physiology | Drug Delivery Systems | Vagus Nerve Stimulation | Brain - metabolism | Anxiety - therapy | Exploratory Behavior - physiology | Desipramine - pharmacology | Oxidopamine - pharmacology | Swimming - psychology | Time Factors | Protein Binding - drug effects | Reaction Time - drug effects | Exploratory Behavior - drug effects | Immobility Response, Tonic - drug effects | Anxiety - metabolism | Disease Models, Animal | Imipramine - pharmacokinetics | Serotonin Antagonists - pharmacokinetics | Sertraline - pharmacology | Anxiety - physiopathology | Rats | 5,7-Dihydroxytryptamine - pharmacology | Adrenergic Agents - pharmacology | Rats, Sprague-Dawley | Feeding Behavior - drug effects | Brain - drug effects | Autoradiography | Animals | Norepinephrine - metabolism | Serotonin Agents - pharmacology | Analysis of Variance | Serotonin - metabolism | Adrenergic Uptake Inhibitors - pharmacology | Norepinephrine - analogs & derivatives | Serotonin Uptake Inhibitors - pharmacology | Tritium - pharmacokinetics | Serotonin | Antianxiety agents | Index Medicus
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 01/2006, Volume 26, Issue 2, pp. 398 - 405
In this study, we investigated the role of orexinergic systems in dopamine-related behaviors induced by the mu-opioid receptor agonist morphine in rodents.... 
Opioid | Morphine | Reward | Addiction | Orexin | Dependence | reward | PROTEIN-KINASE-C | opioid | addiction | RECEPTOR MESSENGER-RNA | SPINAL-CORD | INDUCED HYPERLOCOMOTION | NEUROSCIENCES | morphine | VENTRAL TEGMENTAL AREA | HYPOCRETIN OREXIN | dependence | OPIOID RECEPTORS | orexin | RAT-BRAIN | EXPRESSION | Benzoxazoles - pharmacology | Injections, Intraventricular | Motor Activity - drug effects | Male | Receptors, Opioid, mu - agonists | Ventral Tegmental Area - physiology | Nucleus Accumbens - physiology | RNA, Messenger - biosynthesis | Desipramine - pharmacology | Conditioning, Operant - drug effects | Dopamine - physiology | Injections, Subcutaneous | Urea - analogs & derivatives | Limbic System - physiology | Female | Neuropeptides - genetics | Haloperidol - pharmacology | Limbic System - drug effects | Neuropeptides - deficiency | Ventral Tegmental Area - drug effects | Protein Precursors - genetics | Microinjections | Morphine - pharmacology | Orexins | Mice, Inbred C57BL | Intracellular Signaling Peptides and Proteins | Rats | Tyrosine 3-Monooxygenase - analysis | Rats, Sprague-Dawley | Mice, Inbred ICR | Mice, Knockout | Protein Precursors - deficiency | Oxidopamine - toxicity | Animals | Microdialysis | Mice | Nucleus Accumbens - drug effects | Urea - pharmacology | Receptors, Opioid, mu - physiology | Behavioral | Cognitive | Systems
Journal Article
Neuron, ISSN 0896-6273, 09/2011, Volume 71, Issue 5, pp. 858 - 868
In Parkinson's disease (PD), dopamine depletion alters neuronal activity in the direct and indirect pathways and leads to increased synchrony in the basal... 
BASAL GANGLIA OUTPUT | HIPPOCAMPAL INTERNEURON NETWORKS | SUBTHALAMIC NUCLEUS | GABAERGIC INTERNEURONS | BAC TRANSGENIC MICE | MEDIUM SPINY NEURONS | EXTERNAL GLOBUS-PALLIDUS | STRIATAL NEURONS | NEUROSCIENCES | SYNCHRONIZED GAMMA-OSCILLATIONS | PARKINSONS-DISEASE | Interneurons - physiology | Tyrosine 3-Monooxygenase - metabolism | Sulpiride - pharmacology | Electric Stimulation | Parvalbumins - metabolism | Nerve Net - drug effects | Corpus Striatum - cytology | Excitatory Postsynaptic Potentials - drug effects | Nerve Net - physiology | Dopamine - deficiency | Neural Inhibition - physiology | Desipramine - pharmacology | Oxidopamine - pharmacology | Time Factors | Computer Simulation | Axons - ultrastructure | Sympatholytics - pharmacology | Interneurons - cytology | Lysine - metabolism | Action Potentials - drug effects | Lysine - analogs & derivatives | Enzyme Inhibitors - pharmacology | Interneurons - drug effects | Axons - metabolism | Benzazepines - pharmacology | Biophysics | Action Potentials - physiology | Animals | Interneurons - metabolism | Vesicular Inhibitory Amino Acid Transport Proteins - metabolism | Dopamine Antagonists - pharmacology | Corpus Striatum - drug effects | Mice | Models, Neurological | In Vitro Techniques | Neural Inhibition - drug effects | Pharmacogenetics | Neurosciences | Nervous system diseases | Dopamine | Parkinson's disease | Neurons | Analysis | GABA | Phenols | Mortality | Parkinsons disease | Connectivity | Behavior | Gene expression | Basal ganglia
Journal Article
Journal Article
Journal Article
Psychopharmacology, ISSN 0033-3158, 3/2015, Volume 232, Issue 5, pp. 907 - 915
Journal Article